These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1703770)

  • 1. The specificity of the binding of platelet activating factor (PAF) to anti-PAF antibodies.
    Smal MA; Baldo BA; Harle DG
    J Mol Recognit; 1990 Aug; 3(4):169-73. PubMed ID: 1703770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of internalization of platelet-activating factor in activated human neutrophils. Enhanced transbilayer movement across the plasma membrane.
    Bratton DL; Dreyer E; Kailey JM; Fadok VA; Clay KL; Henson PM
    J Immunol; 1992 Jan; 148(2):514-23. PubMed ID: 1309560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of antibodies to platelet-activating factor.
    Macpherson JL; Spur B; Pyne SG; Heymans F; Cox MF; Godfroid JJ; Krilis SA
    J Lipid Mediat; 1992 Feb; 5(1):49-59. PubMed ID: 1391739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining site specificities of rabbit antibodies to platelet-activating factor (PAF).
    Cooney SJ; Smal MA; Harle DG; Baldo BA
    Mol Immunol; 1990 May; 27(5):405-12. PubMed ID: 2366757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
    Hwang SB; Lam MH; Hsu AH
    Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of platelet-activating factor (PAF) receptor in the rat brain.
    Bito H; Kudo Y; Shimizu T
    J Lipid Mediat; 1993; 6(1-3):169-74. PubMed ID: 8395241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor binding to human platelet membranes.
    Valone FH; Ruis NM
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAF binding to a single receptor in corneal epithelium plasma membrane.
    Hurst J; Ma X; Bazan HE
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of platelet-activating factor receptors on canine T lymphocytes.
    Mangino MJ; Murphy MK; Weiss A; Anderson CB
    J Immunol; 1993 Nov; 151(10):5310-8. PubMed ID: 8228226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine.
    Tordai A; Franklin RA; Johnson C; Mazer BD; Clay KL; Gelfand EW
    J Immunol; 1994 Jan; 152(2):566-73. PubMed ID: 8283038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to platelet-activating factor (PAF) inhibit PAF-induced platelet aggregation.
    Smal MA; Cooney SJ; Baldo BA
    J Lipid Mediat; 1991 Nov; 4(3):333-41. PubMed ID: 1764578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-dependent internalization of platelet-activating factor.
    Gerard NP; Gerard C
    J Immunol; 1994 Jan; 152(2):793-800. PubMed ID: 8283052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O; Robaut C; Cavero I
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Alberts AW; Bugianesi RL; Chabala JC; Ponpipom MM
    J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.